Lybalvi Lybalvi (ixekizumab / methotrexate) is a fixed‑dose combination biologic/antimetabolite indicated for the treatment of moderate to severe plaque psoriasis in adults and adolescents. Mechanism of Action Ixekizumab – a…
Luxiq Luxiq (generic name: luxifib) is an orally active, selective sodium‑channel blocker approved for the management of chronic neuropathic pain. It exhibits a favorable safety profile and once‑daily dosing convenience.…
Lutathera Lutathera (Lutetium‑177 DOTA‑Tyr³-octreotate) is a radiolabeled somatostatin analog approved for peptide receptor‑radionuclide therapy (PRRT) of gastro‑intestinal and bronchial neuroendocrine tumors expressing somatostatin receptors (SSTRs). Mechanism of Action Targeted delivery:…
Lurasidone Lurasidone is an atypical antipsychotic indicated for schizophrenia and bipolar depression. It offers a favorable metabolic profile compared to many other second‑generation antipsychotics. Mechanism of Action Potent D₂ &…
Lunesta Mechanism of Action Lunesta (generic name eszopiclone) is a non‑benzodiazepine hypnotic that selectively augments GABA‑A receptor activity. Binds to the benzodiazepine site on the β3 subunit of GABA‑A receptors,…
Lubiprostone Lubiprostone is a clinically distinct prostaglandin E1 analog that selectively activates chloride channel 2 (ClC‑2) on colonic epithelial cells, promoting fluid secretion and enhancing intestinal transit. Mechanism of Action…
Lovenox Lovenox is the brand name for the low‑molecular‑weight heparin (LMWH) enoxaparin sodium. It is widely prescribed for thromboprophylaxis, treatment of venous thromboembolism (VTE), and prevention of peri‑operative bleeding complications.…
Lovastatin Mechanism of Action Competitive inhibitor of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase (HMG‑CoA reductase), the rate‑limiting enzyme in hepatic cholesterol biosynthesis. Reduces endogenous cholesterol production → up‑regulation of hepatic LDL‑receptor expression →…
Losartan Losartan is a selective angiotensin‑II type‑1 receptor antagonist (ARB) used mainly for antihypertensive therapy and renal protection in diabetic nephropathy. --- Mechanism of Action Losartan competitively blocks AT₁ receptors…